GPX4 and cancer: In cancers with GOF Mutp53, statins can inhibit tumor growth by inducing mutp53 degradation, inhibiting prenylation of oncogenes and cholesterol synthesis, as well as inducing ferroptosis by inhibiting the biosynthesis of GPX4 and CoQ10 (16–18).